glp-1 種類 風靡全球「瘦瘦針」Q & A 不只降血糖、減重， 還可治療脂肪肝？！ Evolution of GLP‐1 Receptor Agonists

Physician-formulated for GLP-1 users

Sanyal AJ

IP glucose tolerance tests (IPGTT) were performed the same way, starting with an IP administration of glucose at 1 g/kg ( n = 6 RD and n = 7 WD)

Acknowledgements This work was supported by grants from National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121804) and National Institute of Food and Agriculture (67017-29252) Ethics declarations Competing interests The authors declare no competing interests

Summary Clinical studies highlight that GLP-1RA to treat obesity, alongside their concomitant cardioprotective effects, have become a hallmark in clinical science

As in the shorter-term studies, DPP-4 inhibition was well-tolerated with no increased risk of hypoglycaemia, despite the improvement in glycaemic control, and the overall adverse event profile was similar in both arms of the study